Embryonic Stem Cells Work

HALF A MIND:©2002, The National Academy of SciencesLesioned brains 16 weeks after embryonic stem cell transplant stain positive for tyrosine hydroxylase (TH: green), dopamine transporter (DAT: red), and aromatic amino acid decar-boxylase (AADC: blue) in an overlaid image. Bar equals 25 μm.Since drawing the attention of scientists, ethicists, and policymakers, stem cells have not lost their place as one of the most promising yet controversial scientific discoveries of the 20th century.

Written byMaria Anderson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

©2002, The National Academy of Sciences

Lesioned brains 16 weeks after embryonic stem cell transplant stain positive for tyrosine hydroxylase (TH: green), dopamine transporter (DAT: red), and aromatic amino acid decar-boxylase (AADC: blue) in an overlaid image. Bar equals 25 μm.

Since drawing the attention of scientists, ethicists, and policymakers, stem cells have not lost their place as one of the most promising yet controversial scientific discoveries of the 20th century. Scientists admit that they still know very little about how these undifferentiated pluripotent precursors work, but they're looking to develop a more sophisticated view, one that will unlock stem cells' therapeutic potential. Many regard embryonic stem cell (ESC) transplant as the ideal therapy for treating conditions such as Parkinson disease and diabetes, since they could replace malfunctioning cells, but so far the results in animal models have been mixed. Indeed, some groups have published different interpretations of seemingly similar ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies